Stephen Kent to Influenza, Human
This is a "connection" page, showing publications Stephen Kent has written about Influenza, Human.
Connection Strength
5.872
-
Randomized trial of same- versus opposite-arm coadministration of inactivated influenza and SARS-CoV-2 mRNA vaccines. JCI Insight. 2025 01 09; 10(4).
Score: 0.689
-
Fc-mediated functions and the treatment of severe respiratory viral infections with passive immunotherapy - a balancing act. Front Immunol. 2023; 14:1307398.
Score: 0.637
-
Poor protective potential of influenza nucleoprotein antibodies despite wide prevalence. Immunol Cell Biol. 2022 01; 100(1):49-60.
Score: 0.553
-
Fc functional antibody responses to adjuvanted versus unadjuvanted seasonal influenza vaccination in community-dwelling older adults. Vaccine. 2020 02 28; 38(10):2368-2377.
Score: 0.490
-
The protective potential of Fc-mediated antibody functions against influenza virus and other viral pathogens. Immunol Cell Biol. 2020 04; 98(4):253-263.
Score: 0.490
-
Antibody-Dependent Cellular Cytotoxicity Responses to Seasonal Influenza Vaccination in Older Adults. J Infect Dis. 2017 12 27; 217(1):12-23.
Score: 0.423
-
Antibody-dependent cellular cytotoxicity and influenza virus. Curr Opin Virol. 2017 02; 22:89-96.
Score: 0.396
-
What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins. EBioMedicine. 2016 Jun; 8:277-290.
Score: 0.377
-
IFN-gene signatures in B cells following influenza A and B virus infection and influenza vaccination. EMBO Mol Med. 2026 04; 18(4):1456-1477.
Score: 0.187
-
Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial. J Infect Dis. 2025 Dec 20; 232(6):1319-1329.
Score: 0.184
-
Immune imprinting in early life shapes cross-reactivity to influenza B virus haemagglutinin. Nat Microbiol. 2024 Aug; 9(8):2073-2083.
Score: 0.166
-
Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza. JCI Insight. 2023 07 24; 8(14).
Score: 0.156
-
Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques. PLoS Pathog. 2022 10; 18(10):e1010891.
Score: 0.147
-
Lung-resident memory B cells established after pulmonary influenza infection display distinct transcriptional and phenotypic profiles. Sci Immunol. 2022 01 28; 7(67):eabf5314.
Score: 0.140
-
Influenza lineage extinction during the COVID-19 pandemic? Nat Rev Microbiol. 2021 12; 19(12):741-742.
Score: 0.139
-
Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous Australians. Proc Natl Acad Sci U S A. 2021 10 12; 118(41).
Score: 0.138
-
From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases. Acta Biomater. 2021 09 01; 131:16-40.
Score: 0.135
-
Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patients. Nat Commun. 2021 05 11; 12(1):2691.
Score: 0.134
-
Anti-Influenza Hyperimmune Immunoglobulin Enhances Fc-Functional Antibody Immunity During Human Influenza Infection. J Infect Dis. 2018 09 22; 218(9):1383-1393.
Score: 0.111
-
Circulating TFH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity. Sci Transl Med. 2018 02 14; 10(428).
Score: 0.107
-
Impact of serum versus anticoagulant-containing plasma on influenza virus neuraminidase-based serological assays. Vaccine. 2026 Jan 01; 69:127956.
Score: 0.046
-
A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA. Nat Commun. 2018 07 10; 9(1):2669.
Score: 0.027